# Fulcrum Therapeutics, Inc.: Form 8-K, filed Feb 27, 2024

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2024-02-27
- Accepted by EDGAR: Feb 27, 2024, 07:01 ET
- Period: 2024-02-27
- Accession: 0000950170-24-020615
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000095017024020615/fulc-20240227.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000095017024020615/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000095017024020615/fulc-20240227.htm

Filed Feb 27, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-020615. Last ingested by Listed: Nov 5, 2026, 11:06 ET. No prices; not investment advice.